SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 273 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $75,954,000 | +22.9% | 388,136 | +6.7% | 0.24% | +12.0% |
| Q2 2020 | $61,800,000 | +25.7% | 363,698 | -14.6% | 0.22% | -0.9% |
| Q1 2020 | $49,156,000 | +60.6% | 426,037 | +59.0% | 0.22% | +113.7% |
| Q4 2019 | $30,611,000 | +167.7% | 267,908 | +47.3% | 0.10% | +200.0% |
| Q1 2017 | $11,435,000 | +39.5% | 181,919 | +17.1% | 0.03% | +36.0% |
| Q4 2016 | $8,195,000 | -55.9% | 155,291 | -54.9% | 0.02% | -56.1% |
| Q3 2016 | $18,589,000 | +118.9% | 344,174 | +63.8% | 0.06% | +111.1% |
| Q2 2016 | $8,493,000 | -12.3% | 210,174 | -16.3% | 0.03% | -6.9% |
| Q3 2015 | $9,683,000 | -34.6% | 251,123 | -18.0% | 0.03% | -25.6% |
| Q2 2015 | $14,815,000 | – | 306,102 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |